The use of bronchoalveolar lavage in diagnosis of infectious
pulmonary complications in immunocompromised patients.

J 2000

The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.

SKŘIČKOVÁ, Jana, Jiří MAYER, Zdeněk MERTA, Jiří VORLÍČEK, Stanislav ŠPELDA et. al.

Základní údaje

Originální název

The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.

Autoři

SKŘIČKOVÁ, Jana (203 Česká republika, garant), Jiří MAYER (203 Česká republika), Zdeněk MERTA (203 Česká republika), Jiří VORLÍČEK (203 Česká republika), Stanislav ŠPELDA (203 Česká republika), Dagmar BURGETOVÁ (203 Česká republika), V. DRAŠAR (203 Česká republika), H. KUNDEROVÁ (203 Česká republika), Vojtěch KUBÁLEK (203 Česká republika), Lev MEZENSKÝ (203 Česká republika), Alena ŠEVČÍKOVÁ (203 Česká republika), H. ŠTROBLOVÁ (203 Česká republika) a Miroslav VOTAVA (203 Česká republika)

Vydání

Journal of Health Management and Public Health, 2000, 1335-1885

Další údaje

Jazyk

angličtina

Typ výsledku

Článek v odborném periodiku

Obor

30203 Respiratory systems

Stát vydavatele

Česká republika

Utajení

není předmětem státního či obchodního tajemství

Kód RIV

RIV/00216224:14110/00:00005994

Organizační jednotka

Lékařská fakulta

Klíčová slova anglicky

Immunocompromised patient - pulmonary infection - bronchoscopy - bronchoalveolar lavage - bronchoalveolar fluid

Změněno: 29. 5. 2003 09:20, prof. MUDr. Jana Skřičková, CSc.

Anotace

V originále

In 151 immunocompromised patients (haematological malignancies with pulmonary disease) bronchoalveolar fluid was examined obtained with bronchoalveolar lavage. In 124 (82.1 %) patinets this contributed to the determination of the etiology of pulmonary disease, we changed or started treatment in 111 (73.5 %) patients and the validity of ongoing therapy was confirmed in 12 (7.9 %) patients. Treatment with antibiotics was started or changed in 79 (52.3 %) patients, with antimycotics in 36 (23.8 %), with antituberculotics in 2 (1.3 %), and with virostatics in 19 (12.6 %) patients; antipneumocystic treatment was started in 19 (12.6 %) patients. In 25 (16.6 %) patients the cytostatic treatment was started or changed. Bronchoalveolar lavage and examination of bronchoalveolar fluid contributed substantially to the diagnostics of pulmonary, chiefly infectious diseases in immunocompromised patients.

Návaznosti

MSM 141100003, záměr

Název: Zevní prostředí - karcinogeneze - onkologie

Investor: Ministerstvo školství, mládeže a tělovýchovy ČR, Zevní prostředí - karcinogeneze - onkologie

Citovat

SKŘIČKOVÁ, Jana, Jiří MAYER, Zdeněk MERTA, Jiří VORLÍČEK, Stanislav ŠPELDA, Dagmar BURGETOVÁ, V. DRAŠAR, H. KUNDEROVÁ, Vojtěch KUBÁLEK, Lev MEZENSKÝ, Alena ŠEVČÍKOVÁ, H. ŠTROBLOVÁ a Miroslav VOTAVA. The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. Journal of Health Management and Public Health. 2000, roč. 5, č. 4, s. 73-80. ISSN 1335-1885.

@article{358241,
   author = {Skřičková, Jana and Mayer, Jiří and Merta, Zdeněk and Vorlíček, Jiří and Špelda, Stanislav and Burgetová, Dagmar and Drašar, V. and Kunderová, H. and Kubálek, Vojtěch and Mezenský, Lev and Ševčíková, Alena and Štroblová, H. and Votava, Miroslav},
   article_number = {4},
   keywords = {Immunocompromised patient - pulmonary infection - bronchoscopy - bronchoalveolar lavage - bronchoalveolar fluid},
   language = {eng},
   issn = {1335-1885},
   journal = {Journal of Health Management and Public Health},
   title = {The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.},
   volume = {5},
   year = {2000}
}

TY  - JOUR
ID  - 358241
AU  - Skřičková, Jana - Mayer, Jiří - Merta, Zdeněk - Vorlíček, Jiří - Špelda, Stanislav - Burgetová, Dagmar - Drašar, V. - Kunderová, H. - Kubálek, Vojtěch - Mezenský, Lev - Ševčíková, Alena - Štroblová, H. - Votava, Miroslav
PY  - 2000
TI  - The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients.
JF  - Journal of Health Management and Public Health
VL  - 5
IS  - 4
SP  - 73
EP  - 73
SN  - 13351885
KW  - Immunocompromised patient - pulmonary infection - bronchoscopy - bronchoalveolar lavage - bronchoalveolar fluid
N2  - In 151 immunocompromised patients (haematological malignancies with pulmonary disease) bronchoalveolar fluid was examined obtained with bronchoalveolar lavage. In 124 (82.1 %) patinets this contributed to the determination of the etiology of pulmonary disease, we changed or started treatment in 111 (73.5 %) patients and the validity of ongoing therapy was confirmed in 12 (7.9 %) patients. Treatment with antibiotics was started or changed in 79 (52.3 %) patients, with antimycotics in 36 (23.8 %), with antituberculotics in 2 (1.3 %), and with virostatics in 19 (12.6 %) patients; antipneumocystic treatment was started in 19 (12.6 %) patients. In 25 (16.6 %) patients the cytostatic treatment was started or changed. Bronchoalveolar lavage and examination of bronchoalveolar fluid contributed substantially to the diagnostics of pulmonary, chiefly infectious diseases in immunocompromised patients.
ER  -

SKŘIČKOVÁ, Jana, Jiří MAYER, Zdeněk MERTA, Jiří VORLÍČEK, Stanislav ŠPELDA, Dagmar BURGETOVÁ, V. DRAŠAR, H. KUNDEROVÁ, Vojtěch KUBÁLEK, Lev MEZENSKÝ, Alena ŠEVČÍKOVÁ, H. ŠTROBLOVÁ a Miroslav VOTAVA. The use of bronchoalveolar lavage in diagnosis of infectious pulmonary complications in immunocompromised patients. \textit{Journal of Health Management and Public Health}. 2000, roč.~5, č.~4, s.~73-80. ISSN~1335-1885.

Podrobný výpis o publikaci